Overview
Akira Takeshita practices in Minato, Japan. Takeshita is rated as an Advanced expert by MediFind in the treatment of Brain Tumor. Their top areas of expertise are Pituitary Tumor, Hypothalamic Tumor, Cushing's disease, and Brain Tumor.
Their clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 17 articles in the study of Brain Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acromegaloid Facial Appearance Syndrome
- AcromegalyTakeshita isAdvanced. Learn about Acromegaly.
- Brain TumorTakeshita isAdvanced. Learn about Brain Tumor.
- Cushing's diseaseTakeshita isAdvanced. Learn about Cushing's disease.
- Hypertrichosis-Acromegaloid Facial Appearance Syndrome
- Hypothalamic TumorTakeshita isAdvanced. Learn about Hypothalamic Tumor.
- Experienced
- Adrenal CancerTakeshita isExperienced. Learn about Adrenal Cancer.
- CraniopharyngiomaTakeshita isExperienced. Learn about Craniopharyngioma.
- Diabetes Insipidus (DI)Takeshita isExperienced. Learn about Diabetes Insipidus (DI).
- HyperthyroidismTakeshita isExperienced. Learn about Hyperthyroidism.
- Multiple Endocrine NeoplasiaTakeshita isExperienced. Learn about Multiple Endocrine Neoplasia.
- Multiple Endocrine Neoplasia Type 1Takeshita isExperienced. Learn about Multiple Endocrine Neoplasia Type 1.